These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37442270)

  • 1. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?
    Sahebkar A; Foroutan Z; Katsiki N; Jamialahmadi T; Mantzoros CS
    Metabolism; 2023 Sep; 146():155659. PubMed ID: 37442270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of ferroptosis in liver pathophysiology.
    Kim KM; Cho SS; Ki SH
    Arch Pharm Res; 2020 Oct; 43(10):985-996. PubMed ID: 33079307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes Ferroptosis-Related Senescence in Adipose Tissue.
    Shu X; Wu J; Zhang T; Ma X; Du Z; Xu J; You J; Wang L; Chen N; Luo M; Wu J
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of ferroptosis in non-alcoholic fatty liver disease.
    Wang S; Liu Z; Geng J; Li L; Feng X
    Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
    Latunde-Dada GO
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1893-1900. PubMed ID: 28552631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
    Forcina GC; Dixon SJ
    Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
    van den Berg EH; Wolters AAB; Dullaart RPF; Moshage H; Zurakowski D; de Meijer VE; Blokzijl H
    Liver Int; 2019 Jul; 39(7):1343-1354. PubMed ID: 30968536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.
    Zhao S; Guo Y; Yin X
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):332. PubMed ID: 38179745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway.
    Kitsugi K; Noritake H; Matsumoto M; Hanaoka T; Umemura M; Yamashita M; Takatori S; Ito J; Ohta K; Chida T; Suda T; Kawata K
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166750. PubMed ID: 37268254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction.
    Pan Y; Tang P; Cao J; Song Q; Zhu L; Ma S; Zhang J
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1512-1518. PubMed ID: 33121683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis as a new therapeutic opportunity for nonviral liver disease.
    Jia M; Zhang H; Qin Q; Hou Y; Zhang X; Chen D; Zhang H; Chen Y
    Eur J Pharmacol; 2021 Oct; 908():174319. PubMed ID: 34252441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis: mechanisms and links with diseases.
    Yan HF; Zou T; Tuo QZ; Xu S; Li H; Belaidi AA; Lei P
    Signal Transduct Target Ther; 2021 Feb; 6(1):49. PubMed ID: 33536413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Ferroptosis on Cardiovascular Diseases.
    Xu J; Pi J; Zhang Y; Zhou J; Zhang S; Wu S
    Mediators Inflamm; 2023; 2023():6653202. PubMed ID: 37181809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis Inhibitors as Potential New Therapeutic Targets for Cardiovascular Disease.
    Shaghaghi Z; Motieian S; Alvandi M; Yazdi A; Asadzadeh B; Farzipour S; Abbasi S
    Mini Rev Med Chem; 2022; 22(17):2271-2286. PubMed ID: 35184711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease.
    Doumas M; Imprialos K; Dimakopoulou A; Stavropoulos K; Binas A; Athyros VG
    Curr Pharm Des; 2018; 24(38):4587-4592. PubMed ID: 30652643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
    Maru D; Hothi A; Bagariya C; Kumar A
    Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.